Greenwood Capital Associates LLC Biolife Solutions Inc Transaction History

Greenwood Capital Associates LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 07, 2023	SELL	$17.19 - $24.34 $1,908 - $2,701	-111 Reduced 0.57%	19,323 $427,000
Q1 2023 May 12, 2023	SELL	$17.67 - $26.07 $6,219 - $9,176	-352 Reduced 1.78%	19,434 $422,000
Q4 2022 Jan 26, 2023	BUY	$16.95 - $25.07 $83,139 - $122,968	4,905 Added 32.96%	19,786 $0
Q3 2022 Nov 10, 2022	BUY	$14.64 - $26.7 $217,857 - $397,322	14,881 New	14,881 $339,000

199

45M

8.2K

Ticker BLFS
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 42,684,400
Market Cap $1.11B
Description
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...

Get notified when there are updates to the investment portfolio of Greenwood Capital Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Greenwood Capital Associates LLC with notifications on news.